Factor VIII (Shire)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor VIII (Shire)

Drug Alias NameFactor VIII autologous cell therapy - Shire PharmaceuticalsFactor VIII cell therapy - Transkaryotic TherapiesFactor VIII autologous cell therapy - Transkaryotic TherapiesFactor VIII cell therapy - Shire Pharmaceuticals

ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesShire Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShire Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A